Analyst Ratings for GlaxoSmithKline (GSK)
GSK Rating Summary
GSK Price Target Summary
- Highest: $70.00 (TD Cowen)
- Lowest: $53.00 (CFRA)
- Average: $61.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$61.50 (+12.8%)
* Over Last 12-Mos
Rating Score: 2.4 / 10
Percentile Rank: 18%
Avg. $ Target:
$61.50 (+12.8%)
* Over Last 12-Mos
Rating Score: 2.4 / 10
Percentile Rank: 18%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2026 | Barclays | James Gordon | Downgrade | Underweight (Equalweight) |
N/A (N/A) |
49.02 (54.51) |
11.2% | Details |
| 11/25/2025 | BofA Securities | Graham Perry | Upgrade | Neutral (Underperform) |
N/A (N/A) |
47.19 (54.51) |
15.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
